Charles River Laboratories International, Inc. (CRL) Stock Price: $189.85+3.41 (+1.83%)
The total return cagr for Charles River Laboratories International, Inc. (CRL) stock is 28.77% over the past 12 months. The 3 year average growth rate is -1.34% and the 5 year cagr is -11.31%. Total return includes dividends reinvested.
The closing share price for Charles River Laboratories International, Inc. (CRL) stock was $189.85 for Tuesday, June 9, 2026, up +1.83% from the previous day.
CRL Price Chart
CRL Key Metrics
See All MetricsCRL Earnings Preview
Next Earnings Date
Aug 5, 2026
57 days away
EPS Estimate
2.73
Revenue Est.
$977.95M
Last Quarter Results
EPS
$2.06
vs Estimate
$1.95
Revenue
$995.83M
vs Estimate
$977.46M
CRL Analyst Ratings
Consensus Rating
Based on 15 analysts
Average Price Target
$212.27
+11.8% upside
Low
$135.00
Current
$189.85
High
$265.00
CRL Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $2.71 | N/A | 5 |
| Q2 2027 | N/A | $3.01 | N/A | 3 |
| Q3 2027 | N/A | $3.21 | N/A | 3 |
| Q4 2027 | N/A | $3.33 | N/A | 5 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $12.32 | N/A | 10 |
| FY 2028 | N/A | $13.49 | N/A | 5 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $976.13M | N/A | 5 |
| Q2 2027 | N/A | $978.27M | N/A | 3 |
| Q3 2027 | N/A | $981.61M | N/A | 3 |
| Q4 2027 | N/A | $984.48M | N/A | 5 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $3.92B | N/A | 10 |
| FY 2028 | N/A | $4.09B | N/A | 5 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
CRL Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1CRL | $9.14B | $189.85 | +1.83% | +28.77% | -11.31% | +8.24% |
CRL Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt